Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Cystic Fibrosis

• Publication date

  2022-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcf.2022.05.013PMID 35690578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR

  2020cited by this paper
• Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids

  2020cited by this paper
• The influence of CFTR complex alleles on precision therapy of cystic fibrosis.

  2019cited by this paper
• Molecular structure of the ATP-bound, phosphorylated human CFTR

  2018cited by this paper
• Structural mechanisms of CFTR function and dysfunction

  2018cited by this paper
• mRNA‐based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity

  2017cited by this paper
• Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis.

  2016cited by this paper
• Increased efficacy of VX-809 in different cellular systems results from an early stabilization effect of F508del-CFTR

  2015cited by this paper
• Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization*♦

  2015cited by this paper
• Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.

  2014cited by this paper
• Control of TMEM16A by INO‐4995 and other inositolphosphates

  2013cited by this paper
• CFTR: effect of ICL2 and ICL4 amino acids in close spatial proximity on the current properties of the channel.

  2013cited by this paper
• The influence of genetics on cystic fibrosis phenotypes.

  2012cited by this paper
• Ivacaftor potentiation of multiple CFTR channels with gating mutations.

  2012cited by this paper
• CFTR mutation analysis and haplotype associations in CF patients.

  2012cited by this paper
• A new complex allele of the CFTR gene partially explains the variable phenotype of the L997F mutation

  2010cited by this paper
• The role of the F508C mutation in congenital bilateral absence of the vas deferens

  2008cited by this paper
• The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating

  2006cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• A mutation in CFTR produces different phenotypes depending on chromosomal background

  1993cited by this paper
• A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator

  1992cited by this paper
• Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene

  1991cited by this paper

• Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis

  2024cites this paper
• Targeted locus amplification reveals heterogeneity between and within CFTR genotypes and association with CFTR function in patient-derived intestinal organoids.

  2023cites this paper
• Charting the path to expanded access for CFTR modulator drugs: the nose knows

  2023cites this paper